Catherine Tuleu, research, inherently translational, ranges from formulation, methodology development to clinical implementation, integrating the following themes: children centric excipient research; repurposing by reformulating for better medicines for children; development of innovative age-appropriate dosage forms (especially for under 5s); administration issues and devices and sensory pharmaceuticsTM (dosage form acceptability and in vitro/in vivo taste assessment). 

Her spin out company senCeuTics Ltd. specializes in pharmaceutical sensory evaluation and offers a full spectrum of preclinical, clinical and paediatric formulation services under one roof. 

She is the founder and chairperson of the European Paediatric Formulation Initiative (EuPFI), a consortium working in a pre-competitive way on paediatric drug formulations.